A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Clinical trial NCT06707922 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06707922
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-18
- Primary completion
- 2029-05-31
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.